AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
by Evelyn Kiapi Matsamura
KAMPALA, Feb. 12 (IPS) -- Mutabazi Enos, 33, is a proud man. He was among the 40 Ugandans who volunteered for the first HIV/AIDS vaccine trials in 1999.
Today, Enos stands as an example, proving to skeptics that the vaccine was not harmful.
"The vaccine is not dangerous," he says.
His family was worried about the vaccine, but being a soldier, Enos decided to risk his life by taking part in the trials, known as 'ALVAC Vaccine Phase I'.
Uganda launched the second round of trials on Feb 10. Dr. Ponsiano Kaleebo, who is in charge of the programme, says 50 volunteers will take part in the second trial: DNA MVA Vaccine Phase I.
DNA - deoxyribonucleic acid - carries genetic information in a cell. MVA is the Modified Vaccinia Ankara.